CPAP therapy is considered to be the standard method for treating inspire sleep apnea, but there are several newer devices on the market, such as Inspire. This device has been approved by the FDA for patients suffering from sleep apnea, and it offers a unique design that makes it easier to use. However, it may be more expensive than a traditional CPAP device, and Medicare may not cover it.
Unlike a CPAP machine, Inspire is surgically implanted in the upper chest. It is designed to treat moderate to severe obstructive sleep apnea. It can reduce daytime sleepiness and the risk of heart attacks, strokes, and Type 2 diabetes.
The device is controlled by a small handheld sleep remote. It sends mild stimulation to the hypoglossal nerve. The stimulation helps open the airway. The device is also designed to be turned off when the patient wakes up.
It has been designed for people who are 18 or older and are not already using a CPAP machine. It may not help everyone, though. The device has also been shown to reduce snoring and daytime sleepiness. It is not recommended for pregnant women.
During the Inspire procedure, the doctor places a small nerve stimulator under the skin of the chest. The device monitors the breathing of the patient and sends an impulse to the tongue when the breath is drawn in. This helps to keep the airway open, reducing the occurrence of obstructive sleep apnea.
Inspire therapy has a high success rate, but it has certain risks. These risks include nerve damage, infection, and swelling at the implant site. The device can also cause tongue abrasion, so people with large tonsils or other medical conditions that might interfere with upper airway control should not undergo this therapy.
During surgery, the doctor uses general anesthesia to implant the device, which takes two to three hours. Most people tolerate the device immediately after surgery. However, a small number of patients experience discomfort in the tongue.
Generally, a person can be eligible for Inspire if he or she has moderate to severe obstructive sleep apnea and has not had success with other sleep apnea treatments. To determine whether or not Inspire is right for you, speak to your physician.
Medicare covers Inspire’s device in patients with obstructive sleep apnea. The device is implanted along the right side of the neck, where the hypoglossal nerve passes. Inspire uses a small sensor to monitor the patient’s breathing. The sensor sends mild stimulation to the hypoglossal nerve. The patient’s tongue is then moved out of the way, preventing it from blocking the airway.
During an outpatient procedure, an Inspire-certified physician inserts the device in the chest. Then, a fiberoptic endoscope is used to view the cross-section of the airway. The doctor can then determine the extent of the pharyngeal tissue collapse.
FDA approval inspire sleep apnea
Whether you are a Medicare beneficiary or a private insurer, you may want to know if your health plan will cover an Inspire sleep apnea implant. Inspire is a new way to treat sleep apnea that has been FDA-approved. This device is implanted into the body and is designed to combat sleep apnea by opening airways during sleep.
Inspire is an implantable device that sends mild stimulation to the hypoglossal nerve, which is the nerve that opens the throat. It can be used to treat sleep apnea, snoring, and other breathing disorders. It is implanted under the skin in the chest and is a safe and effective option for some patients.
Most commercial insurance plans will cover Inspire therapy. The device is used to treat patients who have been unsuccessful using continuous positive airway pressure (CPAP) therapy. It is considered a “low-risk” treatment. It is designed to be a temporary treatment for sleep apnea.
CPAP therapy vs inspire sleep apnea
CPAP therapy and Inspire Sleep Apnea Treatment are both treatment methods for sleep apnea. However, these treatments can differ in terms of costs, benefits, and risks. Both treatments have been proven to reduce the symptoms of sleep apnea. However, only Inspire is approved by the FDA for use in treating sleep apnea.
CPAP therapy blows pressurized air into the airway to prevent airway obstruction. However, the device can be uncomfortable for some patients. The device can also be expensive, especially if you are covered by traditional Medicare. The device also may not be suitable for certain people.
Inspire is a sleep apnea device that is implanted under the skin of the chest. It delivers mild stimulation to the hypoglossal nerve to clear airway obstruction. It is designed to be turned on before bed and off after 8 hours of sleep.